Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation
Servier
Servier
Ricoh USA, Inc.
Var2 Pharmaceuticals
IGM Biosciences, Inc.
Taproot Health
TopAlliance Biosciences
EpicentRx, Inc.
Ipsen
Tracon Pharmaceuticals Inc.
Power Life Sciences Inc.
Emerald Clinical Inc.
Genentech, Inc.
Celgene
AEterna Zentaris
Novartis
Celldex Therapeutics
Valerio Therapeutics
Valerio Therapeutics
INSYS Therapeutics Inc
Infinity Pharmaceuticals, Inc.